Cover Image
市場調查報告書

醫療外包市場分析、預測 (醫療費付款者、供應商、醫藥品、藥理、IT)

Medical Outsourcing Market: By Services (Payer, Provider, Pharmaceutical, Pathology, Information Technology); By End Users (Hospitals, Pharma Laboratories, Clinics); By Geography - (2015-2021)

出版商 IndustryARC 商品編碼 358716
出版日期 內容資訊 英文 233 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫療外包市場分析、預測 (醫療費付款者、供應商、醫藥品、藥理、IT) Medical Outsourcing Market: By Services (Payer, Provider, Pharmaceutical, Pathology, Information Technology); By End Users (Hospitals, Pharma Laboratories, Clinics); By Geography - (2015-2021)
出版日期: 2017年08月21日 內容資訊: 英文 233 Pages
簡介

本報告提供醫療產業上外包的現狀及未來發展的相關調查,市場形勢,市場動態,策略性分析,市場分析 (各服務、終端用戶、地區) ,加上主要企業等相關的系統性資訊。

第1章 醫療外包市場概要

第2章 摘要整理

第3章 醫療外包市場形勢

  • 市場佔有率分析
  • 比較分析
    • 產品基準
    • 專利分析
    • 財務分析的前五名

第4章 醫療外包市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場課題
  • 產業的魅力

第5章 醫療外包市場:策略性分析

  • 價值鏈分析
  • 機會分析
  • 產品生命週期
  • 價格分析

第6章 醫療外包市場:各類服務

  • 醫療費付款者
  • 供應商
  • 醫藥品
  • IT
  • 藥理

第7章 醫療外包市場:各終端用戶

  • 醫藥品產業
  • 醫藥品實驗室
  • 醫院
  • 診所
  • 研究機關

第8章 醫療外包市場:地區分析

  • 美國
  • 歐洲
  • APAC (亞太地區)
  • 其他 (RoW)

第8章 醫療外包市場熵

  • M&A
  • 協定,聯盟&合作,及合資企業

第10章 醫療外包市場企業簡介

  • Accenture
  • Medusind
  • GeBBS
  • Genpact
  • Inventive
  • Cognizant Technology Solutions Corporation
  • Lonza
  • Catalent
  • Boehringer Ingelheim
  • DSM Pharma
  • Quintiles
  • Charles Rivers Laboratories
  • Newmark Grubb Knight Frank
  • Igate Patni
  • Inventive Health Inc.

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Outsourcing is an effective cost-saving strategy in which one company assign the core services or operations of the organization to a provider that focuses in that area of service or operation.

The global market for healthcare outsourcing has been segmented by the different areas of outsourcing, services, applications and end users. Each of these segmentations has been further classified into sub segments to give an in-depth and comprehensive analysis of the healthcare outsourcing market.

This report investigates current scenario of outsourcing in healthcare industry & examines the future advancements in this market.

The report covers the different segment of healthcare where outsourcing is growing rapidly. Report also gives insight of the different services and applications provided by these segments and also evaluate the performance of major companies in this area.

1. Medical Outsourcing- Market Overview

2. Executive Summary

3. Medical Outsourcing - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. Patent Analysis
    • 3.2.3. Top 5 Financials Analysis

4. Medical Outsourcing - Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Medical Outsourcing - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Product lifecycle
  • 5.4. Pricing Analysis

6. Medical Outsourcing Market- By Services

  • 6.1. Payer
    • 6.1.1. Transactional Services
      • 6.1.1.1. Claims Processing
      • 6.1.1.2. Transaction Processing
      • 6.1.1.3. Mailroom
    • 6.1.2. Customer Care
      • 6.1.2.1. Plan Administration
      • 6.1.2.2. Call Centre
      • 6.1.2.3. Contact Technology Services
    • 6.1.3. Communication and Marketing Services
      • 6.1.3.1. Member Recruitment
      • 6.1.3.2. Communications Design and Consulting
    • 6.1.4. Cost Avoidance, Audit and Payment Recovery
      • 6.1.4.1. Third-Party Liability
      • 6.1.4.2. Litigation Services
  • 6.2. Provider
    • 6.2.1. Medical Billing
    • 6.2.2. Medical Coding
    • 6.2.3. Medical Transcriptions
    • 6.2.4. Finance and Account
    • 6.2.5. Improved process tracking and reporting
    • 6.2.6. Pricing maintenance and configuration
  • 6.3. Pharmaceutical
    • 6.3.1. CRO Market
      • 6.3.1.1. Lead identification & Lead optimization Phase
      • 6.3.1.2. Biopharmaceutical Development
      • 6.3.1.3. Biologic Assay Development
      • 6.3.1.4. Pre-clinical phase
      • 6.3.1.5. Clinical Research
      • 6.3.1.5.1. Phase 1 clinical phase
      • 6.3.1.5.2. Phase 2 clinical phase
      • 6.3.1.5.3. Phase 3 clinical phase
      • 6.3.1.5.4. Phase 4 clinical phase
      • 6.3.1.6. Clinical Trials Management
      • 6.3.1.7. Pharmacovigilance
    • 6.3.2. Contract Manufacturing Organization
      • 6.3.2.1. API Manufacturing
      • 6.3.2.2. Formulation Development
      • 6.3.2.3. Stability Studies
      • 6.3.2.4. Method Development
      • 6.3.2.5. Packaging
    • 6.3.3. Data Management Services and Biostatistics
    • 6.3.4. Non-Clinical Services
      • 6.3.4.1. Medical Writing
      • 6.3.4.2. Regulatory Compliance
      • 6.3.4.3. Sales and Marketing
      • 6.3.4.4. SCM and Logistics
  • 6.4. Information Technology
    • 6.4.1. IT Organizational Management
    • 6.4.2. Infrastructure Technology Outsourcing
    • 6.4.3. Data integration tools
    • 6.4.4. Quality, safety and compliance solutions
  • 6.5. Pathology
    • 6.5.1. Transcription services
    • 6.5.2. Testing protocols
    • 6.5.3. Resource management

7. Medical Outsourcing Market, By End Users

  • 7.1. Pharmaceutical Industries
  • 7.2. Pharmaceutical Laboratories
  • 7.3. Hospitals
  • 7.4. Clinics
  • 7.5. Research Institutes

8. Medical Outsourcing Market -Geographic Analysis

  • 8.1. U.S.
  • 8.2. Europe
  • 8.3. APAC
  • 8.4. RoW

9. Market Entropy

  • 9.1. Mergers & Acquisitions
  • 9.2. Agreements, Partnerships, Collaborations, and Joint Ventures

10. Company Profiles

  • 10.1. Accenture
  • 10.2. Medusind
  • 10.3. GeBBS
  • 10.4. Genpact
  • 10.5. Inventive
  • 10.6. Cognizant Technology Solutions Corporation
  • 10.7. Lonza
  • 10.8. Catalent
  • 10.9. Boehringer Ingelheim
  • 10.10. DSM Pharma
  • 10.11. Quintiles
  • 10.12. Charles Rivers Laboratories
  • 10.13. Newmark Grubb Knight Frank
  • 10.14. Igate Patni
  • 10.15. Inventive Health Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top